Annual Total Liabilities
$89.54 M
-$37.31 M-29.41%
31 December 2023
Summary:
Adverum Biotechnologies annual total liabilities is currently $89.54 million, with the most recent change of -$37.31 million (-29.41%) on 31 December 2023. During the last 3 years, it has risen by +$41.32 million (+85.69%). ADVM annual total liabilities is now -29.41% below its all-time high of $126.85 million, reached on 31 December 2022.ADVM Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$90.26 M
+$4.49 M+5.23%
30 September 2024
Summary:
Adverum Biotechnologies quarterly total liabilities is currently $90.26 million, with the most recent change of +$4.49 million (+5.23%) on 30 September 2024. Over the past year, it has dropped by -$3.80 million (-4.04%). ADVM quarterly total liabilities is now -38.60% below its all-time high of $147.00 million, reached on 30 June 2021.ADVM Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADVM Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -29.4% | -4.0% |
| 3 y3 years | +85.7% | -37.6% |
| 5 y5 years | +626.3% | +118.5% |
ADVM Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -29.4% | +85.7% | -37.6% | +5.5% |
| 5 y | 5 years | -29.4% | +626.3% | -38.6% | +118.5% |
| alltime | all time | -29.4% | +6771.9% | -38.6% | +6827.0% |
Adverum Biotechnologies Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $90.26 M(+5.2%) |
| June 2024 | - | $85.77 M(+0.3%) |
| Mar 2024 | - | $85.54 M(-4.5%) |
| Dec 2023 | $89.54 M(-29.4%) | $89.54 M(-4.8%) |
| Sept 2023 | - | $94.06 M(-14.7%) |
| June 2023 | - | $110.27 M(-6.4%) |
| Mar 2023 | - | $117.82 M(-7.1%) |
| Dec 2022 | $126.85 M(+2.7%) | $126.85 M(+2.3%) |
| Sept 2022 | - | $124.03 M(-5.2%) |
| June 2022 | - | $130.83 M(+5.1%) |
| Mar 2022 | - | $124.44 M(+0.7%) |
| Dec 2021 | $123.54 M(+156.2%) | $123.54 M(-14.6%) |
| Sept 2021 | - | $144.58 M(-1.6%) |
| June 2021 | - | $147.00 M(+214.6%) |
| Mar 2021 | - | $46.73 M(-3.1%) |
| Dec 2020 | $48.22 M(+0.9%) | $48.22 M(+12.1%) |
| Sept 2020 | - | $43.00 M(-11.5%) |
| June 2020 | - | $48.61 M(+8.9%) |
| Mar 2020 | - | $44.65 M(-6.5%) |
| Dec 2019 | $47.77 M | $47.77 M(+15.6%) |
| Sept 2019 | - | $41.31 M(+28.5%) |
| June 2019 | - | $32.14 M(-2.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $32.90 M(+166.9%) |
| Dec 2018 | $12.33 M(-31.0%) | $12.33 M(+19.1%) |
| Sept 2018 | - | $10.35 M(-21.2%) |
| June 2018 | - | $13.14 M(+18.2%) |
| Mar 2018 | - | $11.12 M(-37.8%) |
| Dec 2017 | $17.88 M(-5.8%) | $17.88 M(+3.8%) |
| Sept 2017 | - | $17.22 M(+5.0%) |
| June 2017 | - | $16.40 M(-20.2%) |
| Mar 2017 | - | $20.55 M(+8.2%) |
| Dec 2016 | $18.98 M(+61.9%) | $18.98 M(-6.7%) |
| Sept 2016 | - | $20.34 M(+21.9%) |
| June 2016 | - | $16.69 M(+46.8%) |
| Mar 2016 | - | $11.37 M(-3.1%) |
| Dec 2015 | $11.73 M(-5.6%) | $11.73 M(+2.0%) |
| Sept 2015 | - | $11.50 M(-12.1%) |
| June 2015 | - | $13.09 M(+0.6%) |
| Mar 2015 | - | $13.01 M(+4.7%) |
| Dec 2014 | $12.42 M(+853.4%) | $12.42 M(+8.0%) |
| Sept 2014 | - | $11.50 M(-2.1%) |
| June 2014 | - | $11.75 M(+591.6%) |
| Mar 2014 | - | $1.70 M(+30.4%) |
| Dec 2013 | $1.30 M(-5.8%) | $1.30 M |
| Dec 2012 | $1.38 M | - |
FAQ
- What is Adverum Biotechnologies annual total liabilities?
- What is the all time high annual total liabilities for Adverum Biotechnologies?
- What is Adverum Biotechnologies annual total liabilities year-on-year change?
- What is Adverum Biotechnologies quarterly total liabilities?
- What is the all time high quarterly total liabilities for Adverum Biotechnologies?
- What is Adverum Biotechnologies quarterly total liabilities year-on-year change?
What is Adverum Biotechnologies annual total liabilities?
The current annual total liabilities of ADVM is $89.54 M
What is the all time high annual total liabilities for Adverum Biotechnologies?
Adverum Biotechnologies all-time high annual total liabilities is $126.85 M
What is Adverum Biotechnologies annual total liabilities year-on-year change?
Over the past year, ADVM annual total liabilities has changed by -$37.31 M (-29.41%)
What is Adverum Biotechnologies quarterly total liabilities?
The current quarterly total liabilities of ADVM is $90.26 M
What is the all time high quarterly total liabilities for Adverum Biotechnologies?
Adverum Biotechnologies all-time high quarterly total liabilities is $147.00 M
What is Adverum Biotechnologies quarterly total liabilities year-on-year change?
Over the past year, ADVM quarterly total liabilities has changed by -$3.80 M (-4.04%)